Science Explorer Back to mapMap
Discussion
Company · Brussels · Belgium

UCB Pharma (Belgium)

In research, UCB Pharma (Belgium) stands highest in Health Sciences (#4,825 of 9,902 worldwide) and Medicine (#4,325 of 8,541 worldwide), 2022-now.

ucb.comROR OpenAlex
World rank, 2022-now
#12,888
of 22,385 · #3,440 all time
Rank in Belgium
#58
of 105
Research works
1.2k
▼ 8% vs 2018-21
Citations
37k
31.1 per fractional work
Top-10% rate
11.7%
all institutions 10.0%
vs its own fields
1.01×
1.00× is exactly expected
Open access
35%
world 40%
International
49%
world 18%
UCB Pharma (Belgium)

What is UCB Pharma (Belgium) known for in research?

The fields where it stands highest, 2022-now, ranked among every institution above the floor in each field.

FieldWorld rankWhere that sitsTop-10% rateWorksAll time
Health SciencesDomain #4,825 of 9,902 13.4%88 #1882
MedicineField #4,325 of 8,541 13.2%83 #1862

Each strip is that field's whole ranked pool, with the notch where UCB Pharma (Belgium) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no average mark, because the average differs by field (from about 6% in Dentistry to 21% in Economics).

Which fields of science does UCB Pharma (Belgium) work in?

In 2022-now, 51% of research at UCB Pharma (Belgium) is in Health Sciences, 26% in Life Sciences. Its largest fields are Medicine (48%), Biochemistry, Genetics and Molecular Biology (11%), Neuroscience (6%). It does 2.1× the world's share of Health Sciences.

Health Sciences: 95 fractional works · 51.5% of its workMedicine: 89 fractional works · 48.5% of its workRheumatology: 12 fractional works · 6.5% of its workNeurology: 10 fractional works · 5.5% of its workPsychiatry and Mental health: 9 fractional works · 4.6% of its workSurgery: 8 fractional works · 4.3% of its workPediatrics, Perinatology and Child Health: 6 fractional works · 3.1% of its workDermatology: 6 fractional works · 3.1% of its workCardiology and Cardiovascular Medicine: 5 fractional works · 2.5% of its workOncology: 3 fractional works · 1.8% of its workRadiology, Nuclear Medicine and Imaging: 3 fractional works · 1.8% of its workPublic Health, Environmental and Occupational Health: 3 fractional works · 1.6% of its workPhysiology: 3 fractional works · 1.6% of its workEpidemiology: 3 fractional works · 1.6% of its workPulmonary and Respiratory Medicine: 3 fractional works · 1.4% of its workPathology and Forensic Medicine: 2 fractional works · 1.2% of its workOrthopedics and Sports Medicine: 2 fractional works · 1.1% of its workGenetics: 2 fractional works · 0.9% of its workPharmacology: 2 fractional works · 0.9% of its workHematology: 1 fractional works · 0.7% of its workEndocrinology, Diabetes and Metabolism: 1 fractional works · 0.6% of its workInfectious Diseases: 1 fractional works · 0.5% of its workGastroenterology: 1 fractional works · 0.5% of its workEmergency Medicine: 1 fractional works · 0.4% of its workHepatology: 1 fractional works · 0.4% of its workAnatomy: 1 fractional works · 0.3% of its workReproductive Medicine: 0 fractional works · 0.3% of its workCritical Care and Intensive Care Medicine: 0 fractional works · 0.2% of its workSmaller subfields together: 2 fractional works · 0.9% of its workHealth Professions: 3 fractional works · 1.8% of its workGeneral Health Professions: 1 fractional works · 0.7% of its workOccupational Therapy: 1 fractional works · 0.3% of its workPhysical Therapy, Sports Therapy and Rehabilitation: 0 fractional works · 0.3% of its workEmergency Medical Services: 0 fractional works · 0.2% of its workSmaller subfields together: 1 fractional works · 0.3% of its workVeterinary: 1 fractional works · 0.6% of its workSmall Animals: 1 fractional works · 0.6% of its workDentistry: 1 fractional works · 0.3% of its workOral Surgery: 1 fractional works · 0.3% of its workNursing: 1 fractional works · 0.3% of its workNutrition and Dietetics: 1 fractional works · 0.3% of its workLife Sciences: 47 fractional works · 25.5% of its workBiochemistry, Genetics and Molecular Biology: 20 fractional works · 10.7% of its workMolecular Biology: 13 fractional works · 7.0% of its workGenetics: 3 fractional works · 1.4% of its workCell Biology: 1 fractional works · 0.5% of its workClinical Biochemistry: 1 fractional works · 0.4% of its workBiophysics: 1 fractional works · 0.4% of its workCancer Research: 1 fractional works · 0.4% of its workBiotechnology: 0 fractional works · 0.3% of its workSmaller subfields together: 1 fractional works · 0.4% of its workNeuroscience: 12 fractional works · 6.3% of its workCellular and Molecular Neuroscience: 5 fractional works · 2.7% of its workCognitive Neuroscience: 4 fractional works · 1.9% of its workNeurology: 2 fractional works · 1.2% of its workDevelopmental Neuroscience: 1 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.1% of its workImmunology and Microbiology: 10 fractional works · 5.5% of its workImmunology: 10 fractional works · 5.4% of its workSmaller subfields together: 0 fractional works · 0.0% of its workPharmacology, Toxicology and Pharmaceutics: 5 fractional works · 2.7% of its workPharmaceutical Science: 3 fractional works · 1.6% of its workPharmacology: 2 fractional works · 0.9% of its workToxicology: 0 fractional works · 0.2% of its workAgricultural and Biological Sciences: 1 fractional works · 0.4% of its workFood Science: 1 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.1% of its workPhysical Sciences: 29 fractional works · 15.5% of its workEngineering: 10 fractional works · 5.3% of its workBiomedical Engineering: 4 fractional works · 2.1% of its workElectrical and Electronic Engineering: 1 fractional works · 0.8% of its workMechanical Engineering: 1 fractional works · 0.7% of its workComputational Mechanics: 1 fractional works · 0.7% of its workControl and Systems Engineering: 1 fractional works · 0.3% of its workSafety, Risk, Reliability and Quality: 0 fractional works · 0.3% of its workIndustrial and Manufacturing Engineering: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.2% of its workChemistry: 7 fractional works · 3.6% of its workOrganic Chemistry: 3 fractional works · 1.6% of its workSpectroscopy: 1 fractional works · 0.7% of its workAnalytical Chemistry: 1 fractional works · 0.7% of its workPhysical and Theoretical Chemistry: 1 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.2% of its workComputer Science: 6 fractional works · 3.0% of its workComputational Theory and Mathematics: 4 fractional works · 2.1% of its workArtificial Intelligence: 1 fractional works · 0.7% of its workSmaller subfields together: 0 fractional works · 0.2% of its workMaterials Science: 2 fractional works · 1.3% of its workMaterials Chemistry: 2 fractional works · 1.2% of its workSmaller subfields together: 0 fractional works · 0.2% of its workMathematics: 1 fractional works · 0.8% of its workStatistics and Probability: 1 fractional works · 0.7% of its workSmaller subfields together: 0 fractional works · 0.0% of its workPhysics and Astronomy: 1 fractional works · 0.6% of its workAtomic and Molecular Physics, and Optics: 0 fractional works · 0.2% of its workSmaller subfields together: 1 fractional works · 0.3% of its workChemical Engineering: 1 fractional works · 0.4% of its workEnvironmental Science: 1 fractional works · 0.4% of its workEnvironmental Chemistry: 1 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.1% of its workEarth and Planetary Sciences: 0 fractional works · 0.1% of its workEnergy: 0 fractional works · 0.0% of its workSocial Sciences: 14 fractional works · 7.5% of its workEconomics, Econometrics and Finance: 7 fractional works · 3.7% of its workEconomics and Econometrics: 7 fractional works · 3.6% of its workSmaller subfields together: 0 fractional works · 0.0% of its workSocial Sciences: 2 fractional works · 1.1% of its workPolitical Science and International Relations: 1 fractional works · 0.4% of its workSmaller subfields together: 1 fractional works · 0.7% of its workPsychology: 2 fractional works · 1.1% of its workSocial Psychology: 1 fractional works · 0.4% of its workClinical Psychology: 1 fractional works · 0.3% of its workSmaller subfields together: 1 fractional works · 0.3% of its workDecision Sciences: 2 fractional works · 0.9% of its workStatistics, Probability and Uncertainty: 1 fractional works · 0.5% of its workManagement Science and Operations Research: 1 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.1% of its workBusiness, Management and Accounting: 1 fractional works · 0.5% of its workManagement of Technology and Innovation: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.2% of its workArts and Humanities: 0 fractional works · 0.3% of its workALL ITS WORKUCB Pharma(Belgium)185fractional works, 2022-now
Life Sciences26%Physical Sciences16%Health Sciences51%Social Sciences7%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in 2022-now. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 26 fields, with their numbers
    1. Medicine8948.5%
    2. Health Professions31.8%
    3. Veterinary10.6%
    4. Dentistry10.3%
    5. Nursing10.3%
    1. Biochemistry, Genetics and Molecular Biology2010.7%
    2. Neuroscience126.3%
    3. Immunology and Microbiology105.5%
    4. Pharmacology, Toxicology and Pharmaceutics52.7%
    5. Agricultural and Biological Sciences10.4%
    1. Engineering105.3%
    2. Chemistry73.6%
    3. Computer Science63.0%
    4. Materials Science21.3%
    5. Mathematics10.8%
    6. Physics and Astronomy10.6%
    7. Chemical Engineering10.4%
    8. Environmental Science10.4%
    9. Earth and Planetary Sciences00.1%
    10. Energy00.0%
    1. Economics, Econometrics and Finance73.7%
    2. Social Sciences21.1%
    3. Psychology21.1%
    4. Decision Sciences20.9%
    5. Business, Management and Accounting10.5%
    6. Arts and Humanities00.3%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.09× its world share, 1 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 2.01× its world share, 20 worksBiochemistry, Geneti…Immunology and Microbiology: 5.43× its world share, 10 worksImmunology and Micro…Neuroscience: 3.85× its world share, 12 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 7.61× its world share, 5 worksPharmacology, Toxico…Chemical Engineering: 1.29× its world share, 1 worksChemical EngineeringChemistry: 2.31× its world share, 7 worksChemistryComputer Science: 0.39× its world share, 6 worksComputer ScienceEarth and Planetary Sciences: 0.04× its world share, 0 worksEarth and Planetary …Energy: 0.04× its world share, 0 worksEnergyEngineering: 0.35× its world share, 10 worksEngineeringEnvironmental Science: 0.08× its world share, 1 worksEnvironmental ScienceMaterials Science: 0.38× its world share, 2 worksMaterials ScienceMathematics: 0.66× its world share, 1 worksMathematicsPhysics and Astronomy: 0.25× its world share, 1 worksPhysics and AstronomyDentistry: 0.65× its world share, 1 worksDentistryHealth Professions: 0.68× its world share, 3 worksHealth ProfessionsMedicine: 2.52× its world share, 90 worksMedicineNursing: 0.61× its world share, 0 worksNursingVeterinary: 4.38× its world share, 1 worksVeterinaryArts and Humanities: 0.09× its world share, 0 worksArts and HumanitiesBusiness, Management and Accounting: 0.14× its world share, 1 worksBusiness, Management…Decision Sciences: 0.94× its world share, 2 worksDecision SciencesEconomics, Econometrics and Finance: 1.71× its world share, 7 worksEconomics, Econometr…Psychology: 0.35× its world share, 2 worksPsychologySocial Sciences: 0.09× its world share, 2 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 7.6×. Every wedge is a field page.

All 26 fields, with their numbers
  1. Pharmacology, Toxicology and Pharmaceutics7.61×5 works
  2. Immunology and Microbiology5.43×10 works
  3. Veterinary4.38×1 works
  4. Neuroscience3.85×12 works
  5. Medicine2.52×90 works
  6. Chemistry2.31×7 works
  7. Biochemistry, Genetics and Molecular Biology2.01×20 works
  8. Economics, Econometrics and Finance1.71×7 works
  9. Chemical Engineering1.29×1 works
  10. Decision Sciences0.94×2 works
  11. Health Professions0.68×3 works
  12. Mathematics0.66×1 works
  13. Dentistry0.65×1 works
  14. Nursing0.61×0 works
  15. Computer Science0.39×6 works
  16. Materials Science0.38×2 works
  17. Engineering0.35×10 works
  18. Psychology0.35×2 works
  19. Physics and Astronomy0.25×1 works
  20. Business, Management and Accounting0.14×1 works
  21. Agricultural and Biological Sciences0.09×1 works
  22. Arts and Humanities0.09×0 works
  23. Social Sciences0.09×2 works
  24. Environmental Science0.08×1 works
  25. Earth and Planetary Sciences0.04×0 works
  26. Energy0.04×0 works

Who are the top researchers at UCB Pharma (Belgium)?

Ranked on the quality score, Martin Armstrong, Tanja Tran and Henrik Klitgaard lead among researchers whose main affiliation is UCB Pharma (Belgium).

  1. 1 Martin Armstrong Belgium · #301,541 worldwide 3.4k citations · 53 works
  2. 2 Tanja Tran Belgium · #302,551 worldwide 2.3k citations · 30 works
  3. 3 Henrik Klitgaard Belgium · #315,443 worldwide 9.5k citations · 134 works
  4. 4 Alain Matagne Belgium · #333,867 worldwide 5.4k citations · 42 works
  5. 5 Joël Mercier Belgium · #374,741 worldwide 3.8k citations · 77 works
  6. 6 Thomas D. Morel Belgium · #397,946 worldwide 1.5k citations · 60 works
  7. 7 Christophe Génicot Belgium · #427,930 worldwide 3.2k citations · 60 works
  8. 8 Jean‐Philippe Courade Belgium · #489,226 worldwide 1.9k citations · 36 works
  9. 9 Yogesh A. Sabnis Belgium · #541,026 worldwide 1.8k citations · 35 works
  10. 10 ’Matladi N. Ndlovu Belgium · #558,323 worldwide 1.6k citations · 22 works
All ranked researchers at UCB Pharma (Belgium)

What are the most cited papers from UCB Pharma (Belgium)?

The most cited paper from UCB Pharma (Belgium) is "Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016" (Andrew Rhodes et al., 2017), with 3,822 citations. Next come "Romosozumab Treatment in Postmenopausal Women with Osteoporosis" (1,797) and "The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam" (1,624).

Most cited papers
#PaperReleasedCitations
1 Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016 Andrew Rhodes et al. · Critical Care Medicine Open access 18 Jan 2017 3,822
2 Romosozumab Treatment in Postmenopausal Women with Osteoporosis Felicia Cosman, Daria B. Crittenden, Jonathan Derrick Adachi et al. · New England Journal of Medicine Open access 18 Sep 2016 1,797
3 The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam Berkley A. Lynch, Nathalie Lambeng, Karl H. Nocka et al. · Proceedings of the National Academy of Sciences Open access 21 Jun 2004 1,624
4 Romosozumab or Alendronate for Fracture Prevention in Women with Osteoporosis Kenneth G. Saag, JEFFREY E. PETERSEN, Maria Luisa Brandi et al. · New England Journal of Medicine Open access 11 Sep 2017 1,528
5 Prevalence and rate of diagnosis of allergic rhinitis in Europe Vincent Bauchau, Stephen R. Durham · European Respiratory Journal Open access 31 Oct 2004 1,030
All 60 most cited papers, with filters and sorting

Which keywords describe research at UCB Pharma (Belgium)?

By fractional works in 2022-now, weighted toward what it does more of than the world: Inflammation, Antiepileptic Drugs, Quality of Life, Autoantibodies, Genetics, Neurological Disorders, Neurobiology and Epilepsy.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in 2022-now in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Inflammation15▲ 3.9×32 topics
  2. Quality of Life11▲ 4.2×20 topics
  3. Epidemiology10▲ 1.43×46 topics
  4. Oxidative Stress9▲ 2.9×18 topics
  5. Antiepileptic Drugs9▲ 62×2 topics
  6. Genetics9▲ 6.7×9 topics
  7. Autoantibodies8▲ 19×8 topics
  8. Neurological Disorders8▲ 7.3×14 topics
  9. Neurobiology7▲ 15×5 topics
  10. Epilepsy7▲ 35×4 topics
  11. Monoclonal Antibodies7▲ 43×3 topics
  12. Surgery7▲ 11×3 topics
  13. Drug Resistance6▲ 12×6 topics
  14. Neurodegeneration6▲ 11×8 topics
  15. Parkinson's Disease6▲ 13×7 topics
  16. Classification6▲ 7.2×3 topics
  17. Cytokines6▲ 11×5 topics
  18. Immune System6▲ 13×4 topics
  19. Seizures6▲ 50×1 topic
  20. Status Epilepticus6▲ 65×1 topic
  21. TGF-ß6▲ 18×3 topics
  22. Ankylosing Spondylitis5▲ 99×1 topic
  23. Biopharmaceuticals5▲ 56×3 topics
  24. Regulatory T Cells5▲ 25×3 topics
  25. Spondyloarthritis5▲ 99×1 topic
  26. IL-175▲ 79×1 topic
  27. TH17 Cells5▲ 79×1 topic
  28. Medicinal Chemistry5▲ 10×7 topics
  29. Immunogenicity5▲ 63×2 topics
  30. Rheumatoid Arthritis5▲ 27×2 topics
  31. Pharmacokinetics5▲ 9.8×4 topics
  32. Therapeutic Antibodies5▲ 37×2 topics
  33. Cardiovascular Risk5▲ 8.0×5 topics
  34. Cost-effectiveness Analysis5▲ 31×1 topic
  35. Economic Evaluation5▲ 21×2 topics
  36. Health Utility Measures5▲ 31×1 topic
  37. Biological Therapy4▲ 40×2 topics
  38. Immunosuppressive Therapy4▲ 12×6 topics
  39. Disease-Modifying Antirheumatic Drugs4▲ 45×1 topic
  40. Joint Inflammation4▲ 45×1 topic

Which research topics does UCB Pharma (Belgium) publish most on?

By volume in 2022-now: Epilepsy research and treatment, Spondyloarthritis Studies and Treatments, Psoriasis: Treatment and Pathogenesis and Health Systems, Economic Evaluations, Quality of Life.

Epilepsy research and tr…6Epilepsy research and treatment: 6 fractional worksSpondyloarthritis Studie…5Spondyloarthritis Studies and Treatments: 5 fractional worksPsoriasis: Treatment and…5Psoriasis: Treatment and Pathogenesis: 5 fractional worksHealth Systems, Economic…5Health Systems, Economic Evaluations, Quality of Life: 5 fractional worksRheumatoid Arthritis Research and Therapies: 4 fractional worksComputational Drug Discovery Methods: 4 fractional worksHidradenitis Suppurativa…3Hidradenitis Suppurativa and Treatments: 3 fractional worksPharmacological Effects …3Pharmacological Effects and Toxicity Studies: 3 fractional worksNeuroscience and Neuroph…3Neuroscience and Neuropharmacology Research: 3 fractional worksParkinson's Disease Mech…3Parkinson's Disease Mechanisms and Treatments: 3 fractional works
Psychiatry and Mental healthRheumatologyImmunologyEconomics and Econometrics5 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Epilepsy research and treatment Psychiatry and Mental health 6 works
  2. 2 Spondyloarthritis Studies and Treatments Rheumatology 5 works
  3. 3 Psoriasis: Treatment and Pathogenesis Immunology 5 works
  4. 4 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 5 works
  5. 5 Rheumatoid Arthritis Research and Therapies Rheumatology 4 works
  6. 6 Computational Drug Discovery Methods Computational Theory and Mathematics 4 works
  7. 7 Hidradenitis Suppurativa and Treatments Dermatology 3 works
  8. 8 Pharmacological Effects and Toxicity Studies Pediatrics, Perinatology and Child Health 3 works
  9. 9 Neuroscience and Neuropharmacology Research Cellular and Molecular Neuroscience 3 works
  10. 10 Parkinson's Disease Mechanisms and Treatments Neurology 3 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available35.3%not open64.7%

World: 40% of research is openly available.

with international co-authors48.7%domestic only51.3%

World: 18% is written across borders.

How has UCB Pharma (Belgium)'s research output changed?

Output in 2022-2025 was 8% lower than in 2018-2021.

still counting1990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is UCB Pharma (Belgium) as a percentage of every work published that year, 0.00072% in 2024.

still counting0.0010%0.0020%0.0030%UCB Pharma (Belgium)0.00072% in 202519801990200020102020

Fractional works of UCB Pharma (Belgium) over all fractional works that year. How the balance of science has shifted.

How much of it reaches the world top 10%

Year by year, against all institutions in the same year.

still counting10%20%30%UCB Pharma (Belgium)10.5% in 2025all institutions10.0% in 2025200020102020

Of each year's output, the share that reached the world's 10% most cited for its field and year. Peak 21.3% in 2007.

Other research institutions in Brussels

All research institutions in Brussels

Share UCB Pharma (Belgium)'s ranking

UCB Pharma (Belgium) on Science Explorer

A card with UCB Pharma (Belgium)'s standing and the fields it leads in, for a post or a slide. A link to this page previews as the same card.

Download the card

1200 × 630 PNG, sized for social posts, drawn from the latest snapshot.

Badges for a website1Each links back here and updates with every snapshot

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about UCB Pharma (Belgium). Posts are plain text and can be reported.